Dicerna Pharmaceuticals, Inc.
METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF KRAS BY ASYMMETRIC DOUBLE-STRANDED RNA
Last updated:
Abstract:
This invention relates to compounds, compositions, and methods useful for reducing KRAS target RNA and protein levels via use of Dicer substrate siRNA (DsiRNA) agents possessing asymmetric end structures.
Status:
Application
Type:
Utility
Filling date:
22 Jun 2020
Issue date:
8 Oct 2020